Kindstar Globalgene Technology, Inc.

HKSE 9960.HK

Kindstar Globalgene Technology, Inc. Revenue for the year ending December 31, 2023: USD 136.24 M

Kindstar Globalgene Technology, Inc. Revenue is USD 136.24 M for the year ending December 31, 2023, a -32.20% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Kindstar Globalgene Technology, Inc. Revenue for the year ending December 31, 2022 was USD 200.93 M, a 37.18% change year over year.
  • Kindstar Globalgene Technology, Inc. Revenue for the year ending December 31, 2021 was USD 146.47 M, a 7.26% change year over year.
  • Kindstar Globalgene Technology, Inc. Revenue for the year ending December 31, 2020 was USD 136.56 M, a 14.19% change year over year.
  • Kindstar Globalgene Technology, Inc. Revenue for the year ending December 31, 2019 was USD 119.59 M, a 16.47% change year over year.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Loading...
HKSE: 9960.HK

Kindstar Globalgene Technology, Inc.

CEO Dr. Shiang Huang
IPO Date July 16, 2021
Location China
Headquarters Biolake D2-1
Employees 3,193
Sector Health Care
Industries
Description

Kindstar Global (Beijing) Technology, Inc. provides medical esoteric testing services to hospitals in China. Its services include medical research, drug trial, and translational medicine research services for physicians, medical science and technology institutions, specialty and general hospitals, and pharmaceutical companies. The company's lab platforms comprise flow cytometry, cytogenetic, medical genomics, molecular biology, hematopathology, mass spectrum, pathology, clinical immunology, microbiology, and scientific research laboratories. It provides tests in blood, tumor, and genetics; and cardiovascular, cerebrovascular, infectious, and autoimmune diseases, as well as in internal medicine, surgery, gynecology, pediatrics, and other specialties. The company was founded in 2003 and is headquartered in in Wuhan, China.

Similar companies

6622.HK

Zhaoke Ophthalmology Limited

USD 0.18

6.04%

2190.HK

Zylox-Tonbridge Medical Technology Co., Ltd.

USD 1.49

0.32%

9959.HK

Linklogis Inc.

USD 0.18

4.39%

StockViz Staff

January 15, 2025

Any question? Send us an email